107 related articles for article (PubMed ID: 38529542)
1. The antiviral potential of the antiandrogen enzalutamide and the viral-androgen signaling interplay in seasonal coronaviruses.
Ogunjinmi OD; Abdullahi T; Somji RA; Bevan CL; Barclay WS; Temperton N; Brooke GN; Giotis ES
J Med Virol; 2024 Mar; 96(3):e29540. PubMed ID: 38529542
[TBL] [Abstract][Full Text] [Related]
2. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
[TBL] [Abstract][Full Text] [Related]
3. The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells.
Leach DA; Mohr A; Giotis ES; Cil E; Isac AM; Yates LL; Barclay WS; Zwacka RM; Bevan CL; Brooke GN
Nat Commun; 2021 Jul; 12(1):4068. PubMed ID: 34210968
[TBL] [Abstract][Full Text] [Related]
4. Cytopathic Effect Assay and Plaque Assay to Evaluate
Hu Y; Ma C; Wang J
Bio Protoc; 2022 Feb; 12(3):e4314. PubMed ID: 35284599
[TBL] [Abstract][Full Text] [Related]
5. Recapitulating infection, thermal sensitivity and antiviral treatment of seasonal coronaviruses in human airway organoids.
Li P; Wang Y; Lamers MM; Lavrijsen M; Iriondo C; de Vries AC; Rottier RJ; Peppelenbosch MP; Haagmans BL; Pan Q
EBioMedicine; 2022 Jul; 81():104132. PubMed ID: 35779493
[TBL] [Abstract][Full Text] [Related]
6. Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells.
Loo SL; Wark PAB; Esneau C; Nichol KS; Hsu AC; Bartlett NW
Am J Physiol Lung Cell Mol Physiol; 2020 Dec; 319(6):L926-L931. PubMed ID: 32903043
[TBL] [Abstract][Full Text] [Related]
7. Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide.
Li F; Han M; Dai P; Xu W; He J; Tao X; Wu Y; Tong X; Xia X; Guo W; Zhou Y; Li Y; Zhu Y; Zhang X; Liu Z; Aji R; Cai X; Li Y; Qu D; Chen Y; Jiang S; Wang Q; Ji H; Xie Y; Sun Y; Lu L; Gao D
Nat Commun; 2021 Feb; 12(1):866. PubMed ID: 33558541
[TBL] [Abstract][Full Text] [Related]
8. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
Asamoah-Boaheng M; Grunau B; Karim ME; Jassem AN; Bolster J; Marquez AC; Scheuermeyer FX; Goldfarb DM
Front Immunol; 2022; 13():954093. PubMed ID: 36159791
[TBL] [Abstract][Full Text] [Related]
9. Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications for sex-discordant COVID-19 outcomes.
Baratchian M; McManus JM; Berk MP; Nakamura F; Mukhopadhyay S; Xu W; Erzurum S; Drazba J; Peterson J; Klein EA; Gaston B; Sharifi N
Sci Rep; 2021 May; 11(1):11130. PubMed ID: 34045511
[TBL] [Abstract][Full Text] [Related]
10. Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses.
Wang Y; Li P; Solanki K; Li Y; Ma Z; Peppelenbosch MP; Baig MS; Pan Q
Virology; 2021 Dec; 564():33-38. PubMed ID: 34619630
[TBL] [Abstract][Full Text] [Related]
11. Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell.
Hu Y; Jo H; DeGrado WF; Wang J
J Med Virol; 2022 May; 94(5):2188-2200. PubMed ID: 35080027
[TBL] [Abstract][Full Text] [Related]
12. Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses.
Li J; Wang Y; Solanki K; Atre R; Lavrijsen M; Pan Q; Baig MS; Li P
Antiviral Res; 2023 Mar; 211():105555. PubMed ID: 36791846
[TBL] [Abstract][Full Text] [Related]
13. Isolation of Human Coronaviruses OC43, HKU1, NL63, and 229E in Yamagata, Japan, Using Primary Human Airway Epithelium Cells Cultured by Employing an Air-Liquid Interface Culture.
Komabayashi K; Matoba Y; Seto J; Ikeda Y; Tanaka W; Aoki Y; Ikeda T; Matsuzaki Y; Itagaki T; Shirato K; Mizuta K
Jpn J Infect Dis; 2021 Jul; 74(4):285-292. PubMed ID: 33250494
[TBL] [Abstract][Full Text] [Related]
14. An overview on the seven pathogenic human coronaviruses.
Kesheh MM; Hosseini P; Soltani S; Zandi M
Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
[TBL] [Abstract][Full Text] [Related]
15. Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009-2020.
Dyrdak R; Hodcroft EB; Wahlund M; Neher RA; Albert J
J Clin Virol; 2021 Mar; 136():104754. PubMed ID: 33601153
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
Friedman N; Jacob-Hirsch J; Drori Y; Eran E; Kol N; Nayshool O; Mendelson E; Rechavi G; Mandelboim M
PLoS One; 2021; 16(2):e0247128. PubMed ID: 33630927
[TBL] [Abstract][Full Text] [Related]
17. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
[TBL] [Abstract][Full Text] [Related]
18. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data.
Welén K; Rosendal E; Gisslén M; Lenman A; Freyhult E; Fonseca-Rodríguez O; Bremell D; Stranne J; Balkhed ÅÖ; Niward K; Repo J; Robinsson D; Henningsson AJ; Styrke J; Angelin M; Lindquist E; Allard A; Becker M; Rudolfsson S; Buckland R; Carlsson CT; Bjartell A; Nilsson AC; Ahlm C; Connolly AF; Överby AK; Josefsson A
Eur Urol; 2022 Mar; 81(3):285-293. PubMed ID: 34980495
[TBL] [Abstract][Full Text] [Related]
19. Climate and
Kim JM; Jeon JS; Kim JK
J Microbiol Biotechnol; 2020 Oct; 30(10):1495-1499. PubMed ID: 32807752
[TBL] [Abstract][Full Text] [Related]
20. More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro.
Semple SL; Alkie TN; Jenik K; Warner BM; Tailor N; Kobasa D; DeWitte-Orr SJ
Virus Res; 2022 Nov; 321():198925. PubMed ID: 36115551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
